Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 41% ± 20% | |
lung | 12 studies | 25% ± 7% | |
eye | 11 studies | 32% ± 12% | |
peripheral blood | 10 studies | 23% ± 5% | |
heart | 5 studies | 20% ± 4% | |
kidney | 4 studies | 24% ± 1% | |
intestine | 4 studies | 21% ± 4% | |
adipose | 4 studies | 27% ± 3% | |
bone marrow | 3 studies | 23% ± 3% | |
uterus | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 44750.82 | 2642 / 2642 | 100% | 181.07 | 705 / 705 |
esophagus | 100% | 21052.45 | 1445 / 1445 | 100% | 83.51 | 183 / 183 |
intestine | 100% | 20933.50 | 966 / 966 | 100% | 76.52 | 526 / 527 |
skin | 100% | 25663.52 | 1809 / 1809 | 100% | 86.65 | 471 / 472 |
breast | 100% | 19678.38 | 459 / 459 | 100% | 82.48 | 1113 / 1118 |
thymus | 100% | 21750.90 | 653 / 653 | 100% | 98.33 | 602 / 605 |
prostate | 100% | 18643.44 | 245 / 245 | 99% | 51.17 | 499 / 502 |
ovary | 100% | 22305.37 | 180 / 180 | 99% | 61.96 | 427 / 430 |
uterus | 100% | 27952.26 | 170 / 170 | 99% | 62.35 | 454 / 459 |
kidney | 100% | 17647.97 | 89 / 89 | 98% | 63.14 | 887 / 901 |
lung | 100% | 23731.98 | 577 / 578 | 98% | 53.86 | 1130 / 1155 |
stomach | 97% | 12724.30 | 349 / 359 | 100% | 77.24 | 285 / 286 |
bladder | 100% | 20111.38 | 21 / 21 | 95% | 53.47 | 481 / 504 |
adrenal gland | 100% | 16570.20 | 258 / 258 | 95% | 56.10 | 218 / 230 |
pancreas | 74% | 5349.98 | 244 / 328 | 98% | 69.19 | 175 / 178 |
liver | 68% | 4804.72 | 154 / 226 | 98% | 43.38 | 396 / 406 |
adipose | 100% | 22319.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 97.91 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 67.62 | 29 / 29 |
spleen | 100% | 16999.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 58.32 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.25 | 1 / 1 |
blood vessel | 100% | 24418.51 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 16436.77 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 59% | 7532.12 | 551 / 929 | 0% | 0 | 0 / 0 |
muscle | 39% | 2321.46 | 315 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051693 | Biological process | actin filament capping |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0035580 | Cellular component | specific granule lumen |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_1903561 | Cellular component | extracellular vesicle |
GO_0030864 | Cellular component | cortical actin cytoskeleton |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0042995 | Cellular component | cell projection |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0030054 | Cellular component | cell junction |
GO_0008091 | Cellular component | spectrin |
GO_0045296 | Molecular function | cadherin binding |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0051015 | Molecular function | actin filament binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | SPTAN1 |
Protein name | Spectrin alpha, non-erythrocytic 1 SPTAN1 protein Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit) |
Synonyms | NEAS SPTA2 |
Description | FUNCTION: Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane. |
Accessions | ENST00000627441.3 ENST00000704204.1 A0A994J7B0 ENST00000635806.1 ENST00000706487.1 [Q13813-2] ENST00000637867.1 A0A0D9SFF6 ENST00000630804.2 ENST00000630981.1 A0A1B0GW19 A0A1B0GTD1 A0A994J6W6 A0A994J498 ENST00000637032.2 Q13813 ENST00000372731.8 [Q13813-1] A0A5F9ZHC3 A0A994J4G5 ENST00000636337.1 ENST00000704203.1 ENST00000630866.2 ENST00000636257.1 A0A0D9SGF6 A0A1B0GWE2 Q14917 ENST00000358161.9 [Q13813-3] ENST00000672130.1 A0A0D9SF54 ENST00000704206.1 ENST00000636483.1 A0A1B0GTB7 A0A0D9SFH4 ENST00000372739.7 [Q13813-2] ENST00000704205.1 ENST00000704202.1 ENST00000637903.1 ENST00000704207.1 A0A1B0GV13 A0A994J6W3 A0A1B0GUH3 |